Rich, J. N., Desjardins, A., Sathornsumetee, S., Vredenburgh, J. J., Quinn, J. A., Gururangan, S., … Reardon, D. A. (2008). Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma. JOURNAL OF CLINICAL ONCOLOGY, 26(15).

Rich, J. N., A. Desjardins, S. Sathornsumetee, J. J. Vredenburgh, J. A. Quinn, S. Gururangan, A. H. Friedman, H. S. Friedman, and D. A. Reardon. “Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.” JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008).

Rich JN, Desjardins A, Sathornsumetee S, Vredenburgh JJ, Quinn JA, Gururangan S, et al. Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma. JOURNAL OF CLINICAL ONCOLOGY. 2008 May 20;26(15).

Rich, J. N., et al. “Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2008.

Rich JN, Desjardins A, Sathornsumetee S, Vredenburgh JJ, Quinn JA, Gururangan S, Friedman AH, Friedman HS, Reardon DA. Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2008 May 20;26(15).